Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capravirine in HIV-infected patients
NCT00004985Phase 2Completed
- Sponsor
- Agouron Pharmaceuticals
- Start
- Jan 2000
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of capravirine in human immunodeficiency virus infection (HIV), sponsored by Agouron Pharmaceuticals. Started Jan 2000; status: completed.
02
Drugs
capravirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00004985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004985.